novel directions for her2 breast cancer
Published 3 years ago • 17 plays • Length 4:02Download video MP4
Download video MP3
Similar videos
-
5:20
novel approaches for her2-negative metastatic breast cancer
-
9:02
novel therapies in the management of her2-positive breast cancer
-
1:35
advances in novel adcs for her2-expressing breast cancer
-
6:07
updated results from a trial of trastuzumab deruxtecan for her2-positive breast cancer
-
6:25
neoadjuvant and adjuvant therapy for her2-positive breast cancer
-
3:47
novel approaches for stage i her2 breast cancer
-
8:04
management of her2 cancers - integrating new data into clinical practice
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
4:29
novel therapeutic targets for breast cancer
-
3:35
her2 and er breast cancer trials
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
4:45
trastuzumab plus chemotherapy or endocrine therapy for triple-positive breast cancer
-
4:29
novel therapeutic targets for breast cancer
-
3:52
immunotherapy in the neoadjuvant management of her2-positive breast cancer
-
6:40
combination treatment of her2 metastatic breast cancer: first-line therapy
-
8:21
stereotactic radiosurgery in combination with anti-her2 therapy for her2 breast cancer brain mets
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
15:50
spotlight session 8 her2 positive breast cancer novel therapies for her2 advanced breast cancer